Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Sep 4 2014
Washington, D.C. (September 4, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO Investor Forum...
Sep 3 2014
Washington, D.C. (Sept. 3, 2014) –The Biotechnology Industry Organization (BIO) today congratulates member company POET-DSM on opening Project Liberty...
Sep 3 2014
WASHINGTON, D.C. (September 03, 2014) – South Dakota State University, the South Dakota Biotech Association and select Brookings firms will provide...
Aug 25 2014
Washington, D.C. (August 25, 2014) – The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the...
Aug 21 2014
Washington, D.C. (August 21, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce that Dr. Richard Raymond, former...
Aug 6 2014
Washington, D.C. (August 6, 2014) – The Biotechnology Industry Organization (BIO) today announces a first-of-its-kind survey tool on FDA/Sponsor...
Aug 5 2014
Washington, D.C. (August 5, 2014) – The Biotechnology Industry Organization (BIO) has opened registration  for the 13th Annual BIO Investor Forum...
Aug 1 2014
Washington, D.C. (August 1, 2014) – The Biotechnology Industry Organization (BIO) has officially extended its Call for Papers deadline to August 20,...
Jul 31 2014
USDA’s new methods for measuring changes in greenhouse gas emissions from farming and forestry can help industrial biotech companies establish the...


Biotechnology News

September 30, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and...

September 30, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that company Chief Executive Officer Ken...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease...

September 30, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc., a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign...

September 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its third-quarter 2014 financial results Thursday, October 30,...